Physician profile
Vinit Kumar Mahesh
NPI 1790750974
$4,480.27
in general payments reported to CMS, 2019-2025
16 companies · $1,012 in 2025
The $1,012 reported for 2025 was more than what 88% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $605 · 2020: $497 · 2021: $593 · 2022: $600 · 2023: $417 · 2024: $757 · 2025: $1,012.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,151 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,151.18 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,906.70 | 2019-2025 | Tezspire, Fasenra |
| Genzyme Corporation | $887.38 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $533.94 | 2019-2025 | Dupixent |
| Glaxosmithkline, LLC. | $315.09 | 2020-2025 | Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $141.50 | 2019-2021 | |
| Philips North America LLC | $140.05 | 2019-2021 | |
| Gilead Sciences, INC. | $121.20 | 2019-2021 | |
| Amgen INC. | $116.02 | 2022-2025 | Tezspire |
| Abbvie INC. | $94.56 | 2019-2024 | |
| Pharming Healthcare, INC. | $87.79 | 2022-2024 | Ruconest |
| Merck Sharp & Dohme LLC | $33.46 | 2019 | |
| Sobi, INC | $28.79 | 2021 | |
| Chiesi USA, INC. | $21.22 | 2019 | |
| Genentech USA, INC. | $20.99 | 2023 | Pulmozyme |
| Sanofi Pasteur INC. | $17.98 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $13.60 | 2025 | Flucelvax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinit Mahesh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.